Antibody Fragments Market is Projected to Reach USD 7.8 Billion by 2033, Driven by Cancer Therapy Advancements
The global antibody fragments market has firmly established its importance in biopharmaceuticals and diagnostics by 2024, achieving a valuation of approximately USD 8,563 million. Growth to this level has been driven by increasing incidence of chronic and immunological disorders, rising demand for more precise and targeted therapies, and improvements in biologic technologies.Antibody fragments,...
0 Σχόλια 0 Μοιράστηκε 44 Views